Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 73, Topic 5
In Progress

Recovery, De-escalation, and Transition of Care in Pandemic & Emerging Viral Infections

Lesson Progress
0% Complete
Recovery and De-escalation in Critical Viral Illness

Recovery, De-escalation, and Transition of Care in Pandemic & Emerging Viral Infections

Objective Icon A target symbol, representing a key objective.

Objective

Develop and implement standardized protocols for weaning intensive therapies, converting IV to enteral medications, mitigating Post-ICU Syndrome, reconciling medications, and ensuring seamless outpatient transition after critical viral illness.

1. Weaning & De-escalation of Intensive Therapies

As patients recover from critical viral illness, a systematic approach to liberating them from life support is crucial. Daily readiness assessments guide the weaning of mechanical ventilation and vasopressors, aiming to minimize iatrogenic harm and accelerate recovery.

Spontaneous Breathing Trial (SBT) Protocol

The SBT is a cornerstone of ventilator liberation. The process involves screening for readiness, conducting a timed trial, and evaluating for success or failure.

Spontaneous Breathing Trial (SBT) Parameters
Parameter Readiness Criteria Failure Triggers
Oxygenation PaO₂/FiO₂ ≥ 150–200 SpO₂ < 88–90% for > 5 min
Ventilator Support PEEP ≤ 5 cm H₂O, Pressure Support ≤ 7 cm H₂O
Hemodynamics Stable (no new or escalating vasopressors) Heart Rate > 140 bpm or sustained 20% change
Respiratory Effective cough and airway protection Respiratory Rate > 35/min for > 5 min
Neurologic Status Awake, alert, and following commands Agitation, diaphoresis, altered mental status

Following a successful SBT, clinicians assess for extubation readiness by confirming mental status, secretion control, and, in high-risk patients (e.g., intubated >7 days), performing a cuff-leak test to screen for laryngeal edema. For patients with ARDS, prophylactic non-invasive ventilation (NIV) may be considered post-extubation, with appropriate aerosol precautions.

Protocolized De-escalation Algorithm

A structured, multidisciplinary approach integrates weaning protocols. Daily rounds involving critical care pharmacists are key to identifying and overcoming barriers like excessive sedation or untreated infections.

Ventilator Weaning Flowchart A flowchart showing the daily process for ventilator weaning: starting with sedation interruption, moving to an SBT readiness screen, then the SBT itself, and finally an extubation decision. Daily Sedation Interruption SBT Readiness Screen Perform SBT (30-120 min) Extubation
Figure 1: Daily Ventilator Liberation Protocol. This process is performed daily to maximize ventilator-free days and reduce reintubation rates.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Key Pearls: Weaning Therapies +
  • Combine SATs with SBTs: Coordinating daily Spontaneous Awakening Trials (SATs) with Spontaneous Breathing Trials (SBTs) has been shown to shorten mechanical ventilation time and overall ICU length of stay.
  • Avoid Abrupt Vasopressor Withdrawal: Taper vasopressors gradually (e.g., by 10–20% every 2–4 hours) while closely monitoring hemodynamics to prevent rebound hypotension. Low-dose vasopressin (0.03 U/min) can facilitate norepinephrine weaning.

2. Intravenous to Enteral Medication Conversion

Transitioning medications from intravenous (IV) to enteral (PO/NGT) routes is a key step in de-escalation. This process requires careful consideration of gastrointestinal function, drug bioavailability, potential interactions with enteral nutrition, and proper tube maintenance.

Assessment and Management

  • Assess GI Function: Look for signs of GI dysfunction common in post-critical illness, such as reduced motility, mucosal edema, or low perfusion. If gastric retention is present, consider prokinetic agents like metoclopramide.
  • Manage Feed-Drug Interactions: For drugs like phenytoin, fluoroquinolones, and levothyroxine, hold continuous enteral feeds for 1–2 hours before and after administration to ensure adequate absorption.
  • Ensure Tube Patency: To prevent clogging, flush feeding tubes with 20–30 mL of water before and after each medication. If a clog occurs, use enzymatic decloggers first; tube replacement is a last resort.
  • Timing and Monitoring: Initiate the IV-to-enteral switch once the patient tolerates enteral nutrition. Closely monitor clinical effects (e.g., blood pressure, sedation scores, INR) over the next 24–48 hours to ensure therapeutic equivalence.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Key Pearls: IV to Enteral Conversion +
  • Do Not Crush: Never crush enteric-coated or extended-release formulations, as this destroys their delivery mechanism. Consult a pharmacist to find suitable liquid alternatives or immediate-release versions.
  • Bioavailability Changes: Be aware that drugs with high first-pass metabolism (e.g., some beta-blockers, opioids) will have significantly reduced bioavailability when given enterally compared to IV. Dose adjustments are often necessary.

3. Post-ICU Syndrome (PICS) Mitigation

Survivors of critical illness frequently suffer from Post-ICU Syndrome (PICS), a constellation of new or worsened impairments in physical, cognitive, and mental health. Proactive, bundled interventions are essential to reduce this long-term morbidity.

The ABCDEF Bundle

Implementing the ABCDEF bundle is a evidence-based, multidisciplinary strategy to improve patient outcomes. It focuses on integrating best practices for pain, sedation, delirium, and mobility.

  • A
    Assess, prevent, and manage pain: Use validated pain scales (like CPOT) and a multimodal analgesia approach to minimize opioid use.
  • B
    Both Spontaneous Awakening and Breathing trials: Coordinate daily sedation holidays with SBTs to facilitate ventilator liberation.
  • C
    Choice of sedation: Prefer light sedation with agents like dexmedetomidine or propofol; avoid benzodiazepines, which are strongly linked to delirium.
  • D
    Delirium prevention/management: Implement non-pharmacologic strategies like promoting normal sleep-wake cycles, reorientation, and using sensory aids. Limit antipsychotic use to cases of severe agitation.
  • E
    Early mobility: Begin passive range of motion within 48 hours of admission and progress to active exercises and ambulation as tolerated.
  • F
    Family engagement and psychosocial support: Involve family in care, provide regular updates, and support their role in the patient’s recovery.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Key Pearls: PICS Mitigation +
  • Target Light Sedation: Aim for a Richmond Agitation-Sedation Scale (RASS) score of −1 (drowsy) to 0 (alert and calm) to balance patient comfort with the need to minimize sedation depth and duration.
  • Mobility is Medicine: Early mobilization is one of the most effective interventions to reduce the incidence and duration of delirium and improve long-term functional outcomes.

4. Medication Reconciliation & Discharge Counseling

A meticulous medication reconciliation process and comprehensive patient education are critical safety measures during the transition from ICU to the ward and then to home. This prevents errors, supports adherence, and empowers patients to monitor for delayed complications.

Inpatient Review & Deprescribing

The first step is a thorough review of all medications. Compare the pre-admission medication list with the current ICU regimen. Actively deprescribe therapies that are no longer indicated, such as stress-ulcer prophylaxis (PPIs), antipsychotics, and sedatives. Use checklists to clearly document which medications were held, stopped, or changed, and create a clear plan for restarting chronic therapies.

Education Checklist for Discharge

Patient and caregiver education should be structured and confirmed with teach-back methods. Key topics include:

  1. Antiviral Completion: Clearly explain the dosing schedule, potential side effects, and strategies to ensure the full course is completed.
  2. Monitoring for Delayed Complications: Teach patients to watch for signs of post-viral sequelae, such as new or worsening dyspnea, leg swelling (thromboembolism), or cognitive changes (“brain fog”).
  3. Escalation Protocol: Provide a clear, written plan with red-flag symptoms that should prompt a call to their provider or an emergency visit, including 24/7 contact numbers.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Key Pearls: Medication Safety +
  • Employ Teach-Back: Don’t just ask “Do you have any questions?”. Ask the patient or caregiver to explain the plan back to you in their own words (e.g., “Can you tell me how you’re going to take this medication?”). This confirms true understanding.
  • Provide Summaries: Give the patient a clear, written summary of their medication plan and ensure an electronic copy is sent to their outpatient providers to close the communication loop.

5. Seamless Transition to Outpatient Care

Ensuring a safe and effective transition from hospital to home requires structured handoffs, timely follow-up appointments, and the integration of technology like telemedicine to bridge gaps in care.

Structured Handoff and Coordination

Use a standardized handoff tool, such as the I-PASS mnemonic, to communicate critical information to outpatient providers:

  • Illness severity
  • Patient summary
  • Action list (including pending labs, imaging, and medication changes)
  • Situation awareness and contingency planning
  • Synthesis by receiver

Coordinate with outpatient clinics to schedule follow-up appointments within 7–14 days of discharge. This should include primary care and any necessary specialists (e.g., infectious disease, pulmonology, rehabilitation).

Telemedicine Integration

Telehealth plays a vital role in post-discharge care, especially for patients in rural areas or with mobility challenges. It can be used for:

  • Remote Monitoring: Tracking vital signs like pulse oximetry and blood pressure.
  • Medication Adherence Checks: Virtual “pill counts” and counseling.
  • Rehabilitation: Virtual cognitive and functional assessments and guided physical therapy.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Key Pearls: Continuity of Care +
  • Post-ICU Clinics Work: Structured, multidisciplinary post-ICU follow-up clinics have been shown to reduce hospital readmissions by approximately 15% and improve patient-reported outcomes.
  • Telehealth Extends Access: Leveraging telehealth can significantly extend the reach of specialist care, ensuring that survivors in remote or underserved areas receive necessary follow-up for complex post-viral sequelae.

References

  1. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for pain, agitation/sedation, delirium, immobility, and sleep disruption in adult ICU patients. Crit Care Med. 2018;46(9):e825–e873.
  2. Barr J, Fraser GL, Puntillo K, et al. Management of pain, agitation, and delirium in adult ICU patients. Crit Care Med. 2013;41(1):263–306.
  3. Bechtold ML, Karamchandani K, Vines D. When is enteral nutrition indicated? J Parenter Enteral Nutr. 2022;46(7):1470–1496.
  4. Bhimraj A, Morgan RL, Shumaker AH, et al. IDSA guidelines on treatment and management of COVID-19. Clin Infect Dis. 2024;78(7):e250–e349.